Docetaxel, cisplatin, and 5-fluorouracil
✍
Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 86 KB
👁 2 views
## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime